{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06347003",
            "orgStudyIdInfo": {
                "id": "AROAPOC3-3003"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-509300-14",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Arrowhead Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia",
            "officialTitle": "Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Severe Hypertriglyceridemia",
            "acronym": "SHASTA-3",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-plozasiran-aro-in-adults-with-severe-hypertriglyceridemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-29",
            "studyFirstSubmitQcDate": "2024-03-29",
            "studyFirstPostDateStruct": {
                "date": "2024-04-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Arrowhead Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo, and be evaluated for efficacy and safety. After month 12, eligible participants will be offered an opportunity to continue in an optional open-label extension under a separate protocol."
        },
        "conditionsModule": {
            "conditions": [
                "Severe Hypertriglyceridemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 405,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Plozasiran Injection",
                    "type": "EXPERIMENTAL",
                    "description": "4 doses of plozasiran (ARO-APOC3) by subcutaneous (sc) injection",
                    "interventionNames": [
                        "Drug: Plozasiran Injection"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "calculated volume to match active treatment by sc injection",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Plozasiran Injection",
                    "description": "ARO-APOC3 Injection",
                    "armGroupLabels": [
                        "Plozasiran Injection"
                    ],
                    "otherNames": [
                        "ARO-APOC3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "sterile normal saline (0.9% NaCl)",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent Change in Fasting Serum Triglyceride (TG) Levels from Baseline to Month 12 Compared to Placebo",
                    "timeFrame": "Baseline, Month 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percent Change in Fasting Serum TG Levels from Baseline to Month 10 Compared to Placebo",
                    "timeFrame": "Baseline, Month 10"
                },
                {
                    "measure": "Proportion of Participants Who Achieve Fasting TG Levels of <500 mg/dL (<5.65 mmol/L) at Month 10 and Month 12 Compared to Placebo",
                    "timeFrame": "Month 10, Month 12"
                },
                {
                    "measure": "Adjudicated Abdominal Clinical Event Rate (Including Emergency Room Visits or Hospitalizations for Abdominal Pain Attributed to Hypertriglyceridemia and Events of Documented Pancreatitis) During the Treatment Period Compared to Placebo at Month 12",
                    "timeFrame": "Month 12"
                },
                {
                    "measure": "Proportion of Participants Who Achieve Fasting TG Levels of <150 mg/dL (<1.69 mmol/L) at Month 10 and Month 12 Compared to Placebo",
                    "timeFrame": "Month 10, Month 12"
                },
                {
                    "measure": "Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs) Over Time through Month 12 as Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of New-Onset Diabetes Mellitus (NODM) Throughout the Course of Treatment",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of Impaired Glucose Tolerance Throughout the Course of Treatment",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of Worsening of Existing Diabetes Throughout the Course of Treatment",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Hemoglobin A1c (HbA1c) During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Fasting Blood Glucose During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in C-peptide During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of Treatment-Emergent Adverse Events (TEAEs) and Treatment-Related Adverse Events (TRAEs) Associated with Worsening Glycemic Control During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Initiation of New Medication for Hyperglycemia Among Study Participants Not Known to Have Pre-existing Diabetes Mellitus During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Adjudicated Major Adverse Cardiovascular Events (MACE) Rates During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence of Anti-drug Antibodies (ADA) to Plozasiran in Participants Receiving Plozasiran Over Time Through Month 12",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Titers of Anti-drug Antibodies (ADA) to Plozasiran in Participants Receiving Plozasiran Over Time Through Month 12",
                    "timeFrame": "From first dose of study drug through Month 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Established diagnosis of severe hypertriglyceridemia (SHTG) and prior documented evidence (medical history) of fasting TG levels of \u2265 500 mg/dL (\u22655.65mmol/L)\n* Mean fasting TG level \u2265500 mg/dL (\u22655.65 mmol/L) collected at 2 separate and consecutive visits at least 7 days apart and no more than 17 days apart during the screening period\n* Fasting low density lipoprotein-cholesterol (LDL-C) \u2264130 mg/dL (\u22643.37 mmol/L) at screening\n* Screening HbA1C \u22648.5%\n* Willing to follow diet counseling and maintain a stable low-fat diet\n* Must be on standard of care lipid-lowering medications per local guidelines (unless documented as intolerant as determined by the Investigator)\n\nExclusion Criteria:\n\n* Use of any hepatocyte-targeted small interfering ribonucleic acid (siRNA) that targets lipids and/or triglycerides within 365 days before Day 1 (except inclisiran, which is permitted). Administration of investigational drug and inclisiran must be separated by at least 4 weeks\n* Use of any other hepatocyte-targeted siRNA or antisense oligonucleotide molecule within 60 days or within 5-half-lives before Day 1 based on plasma pharmacokinetics (PK), whichever is longer\n* Known diagnosis of familial chylomicronemia syndrome (FCS) (type 1 Hyperlipoproteinemia) by documentation of confirmed homozygote or double heterozygote for loss-of-function mutations in type 1-causing genes\n* Acute pancreatitis within 4 weeks prior to screening\n* Body mass index \\>45kg/m\\^2\n\nNote: Additional Inclusion/Exclusion criteria may apply per protocol",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Medical Monitor",
                    "role": "CONTACT",
                    "phone": "626-304-3400",
                    "email": "plozasiran@arrowheadpharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "National Institute of Clinical Research",
                    "status": "RECRUITING",
                    "city": "Garden Grove",
                    "state": "California",
                    "zip": "92844",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Dao",
                            "role": "CONTACT",
                            "phone": "714-462-2000",
                            "email": "tpalmares@nicresearch.com"
                        },
                        {
                            "name": "Michael Dao, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.77391,
                        "lon": -117.94145
                    }
                },
                {
                    "facility": "Velocity Clinical Research, Panorama City",
                    "status": "RECRUITING",
                    "city": "Panorama City",
                    "state": "California",
                    "zip": "91402",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sandra Sandoval",
                            "role": "CONTACT",
                            "phone": "818-532-6880",
                            "email": "Ssandoval@velocityclinical.com"
                        },
                        {
                            "name": "Robert Jenders, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.22473,
                        "lon": -118.44981
                    }
                },
                {
                    "facility": "Legacy Clinical Trials",
                    "status": "RECRUITING",
                    "city": "Colorado Springs",
                    "state": "Colorado",
                    "zip": "80909",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maxwell Shadd",
                            "role": "CONTACT",
                            "phone": "719-428-2065",
                            "email": "Mshadd@legacyct.net"
                        },
                        {
                            "name": "David Bird, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.83388,
                        "lon": -104.82136
                    }
                },
                {
                    "facility": "Panax Clinical Research",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Miami Lakes",
                    "state": "Florida",
                    "zip": "33014",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nicole M Revoredo",
                            "role": "CONTACT",
                            "phone": "305-698-4500",
                            "email": "nrevoredo@panaxcr.com"
                        },
                        {
                            "name": "Robert Perry, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.90871,
                        "lon": -80.30866
                    }
                },
                {
                    "facility": "Florida Institute for Clinical Research",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32825",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "V. Velez",
                            "role": "CONTACT",
                            "phone": "407-658-0966",
                            "email": "vvelez@ficresearch.com"
                        },
                        {
                            "name": "Humberto Cruz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Meridian Clinical Research",
                    "status": "RECRUITING",
                    "city": "Savannah",
                    "state": "Georgia",
                    "zip": "31401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Felix Cueto",
                            "role": "CONTACT",
                            "phone": "912-443-4253",
                            "email": "FCueto@velocityclinical.com"
                        },
                        {
                            "name": "Paul Bradley, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08354,
                        "lon": -81.09983
                    }
                },
                {
                    "facility": "Elite Clinical Research Center",
                    "status": "RECRUITING",
                    "city": "Flint",
                    "state": "Michigan",
                    "zip": "48532",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jamal Hammoud",
                            "role": "CONTACT",
                            "phone": "810-820-9853",
                            "email": "WH@researchecrc.com"
                        },
                        {
                            "name": "Jamal Hammoud, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01253,
                        "lon": -83.68746
                    }
                },
                {
                    "facility": "Jefferson City Medical Group",
                    "status": "RECRUITING",
                    "city": "Jefferson City",
                    "state": "Missouri",
                    "zip": "65109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christopher Case",
                            "role": "CONTACT",
                            "phone": "573-556-7785",
                            "email": "ccase@jcmg.org"
                        },
                        {
                            "name": "Christopher Case, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.5767,
                        "lon": -92.17352
                    }
                },
                {
                    "facility": "Midwest Regional Health Services LLC",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68144",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kenneth Blad",
                            "role": "CONTACT",
                            "phone": "402-983-8348",
                            "email": "kennethblad@cctresearch.com"
                        },
                        {
                            "name": "Kenneth Blad, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "Santa Rosa Medical Centers of Nevada",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89119",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Richa Jha",
                            "role": "CONTACT",
                            "phone": "725-237-2605",
                            "email": "richajha@cctresearch.com"
                        },
                        {
                            "name": "Syed Pervaiz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "CHEAR Center LLC",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Bernard",
                            "role": "CONTACT",
                            "phone": "347-270-1111",
                            "email": "jorge@chearcenter.com"
                        },
                        {
                            "name": "David Bernard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Endocrine Associates of West Village",
                    "status": "RECRUITING",
                    "city": "Long Island City",
                    "state": "New York",
                    "zip": "11106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jamie R Hyatt",
                            "role": "CONTACT",
                            "phone": "718-704-5376",
                            "phoneExt": "143",
                            "email": "jhyatt@endocrinenyc.com"
                        },
                        {
                            "name": "Anastasios Manessis, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.74482,
                        "lon": -73.94875
                    }
                },
                {
                    "facility": "Endocrine Associates of West Village",
                    "status": "RECRUITING",
                    "city": "Long Island City",
                    "state": "New York",
                    "zip": "11106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James R Hyatt",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Anastasios Manessis, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.74482,
                        "lon": -73.94875
                    }
                },
                {
                    "facility": "Lynn Institute of Norman",
                    "status": "RECRUITING",
                    "city": "Norman",
                    "state": "Oklahoma",
                    "zip": "73072",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samantha Ting",
                            "role": "CONTACT",
                            "phone": "405-701-2828",
                            "email": "sting@lhsi.net"
                        },
                        {
                            "name": "Lubna Mirza, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.22257,
                        "lon": -97.43948
                    }
                },
                {
                    "facility": "Lynn Health Science Institute",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73111",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aquilla Smith",
                            "role": "CONTACT",
                            "phone": "405-602-3938",
                            "email": "asmith@lhsi.net"
                        },
                        {
                            "name": "Charles Lunn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "Cardiovascular Research Center of Knoxville",
                    "status": "RECRUITING",
                    "city": "Powell",
                    "state": "Tennessee",
                    "zip": "37849",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "L. Treasure",
                            "role": "CONTACT",
                            "phone": "865-385-1820",
                            "email": "ltreasure@crknox.net"
                        },
                        {
                            "name": "Charles Treasure, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.03175,
                        "lon": -84.02797
                    }
                },
                {
                    "facility": "Synergy Groups Medical",
                    "status": "RECRUITING",
                    "city": "Missouri City",
                    "state": "Texas",
                    "zip": "77459",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Deirdre McMullen",
                            "role": "CONTACT",
                            "phone": "832-532-4210",
                            "email": "glopez@synergygroupus.com"
                        },
                        {
                            "name": "Deirdre McMullen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.61857,
                        "lon": -95.53772
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015228",
                    "term": "Hypertriglyceridemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006949",
                    "term": "Hyperlipidemias"
                },
                {
                    "id": "D000050171",
                    "term": "Dyslipidemias"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17932",
                    "name": "Hypertriglyceridemia",
                    "asFound": "Hypertriglyceridemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10000",
                    "name": "Hyperlipidemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M10002",
                    "name": "Hyperlipoproteinemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M26181",
                    "name": "Dyslipidemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}